(주)오토파지사이언스 / AUTOPHAGY SCIENCES INC
AUTOPHAGY SCIENCES INC's KOBDi Score is 43.37 as of Sep 2026, up 0.32 points since Apr 2025; it rose in 2 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 68% of companies in its industry, against 68% in Aug 2026 and 67% in Apr 2025. Its strongest position was 69% (Jul 2026) and its weakest 67% (Aug 2025).
A year earlier, in Aug 2025, its score was 43.21 and it was ahead of about 67% of companies in its industry.
| Sep 2026 | 43.37 | ahead of 68% |
| Aug 2026 | 43.37 | ahead of 68% |
| Jul 2026 | 43.37 | ahead of 69% |
| Jun 2026 | 43.21 | ahead of 68% |
| May 2026 | 43.21 | ahead of 68% |
| Apr 2026 | 43.21 | ahead of 68% |
| Mar 2026 | 43.21 | ahead of 69% |
| Feb 2026 | 43.21 | ahead of 69% |
| Dec 2025 | 43.21 | ahead of 69% |
| Aug 2025 | 43.21 | ahead of 67% |
| Jul 2025 | 43.21 | ahead of 68% |
| May 2025 | 43.05 | ahead of 68% |
| Apr 2025 | 43.05 | ahead of 67% |
| # | ||||
|---|---|---|---|---|
| (주)이노셀젠 Inoselgen Co., Ltd. | 5–9 | #405 | ||
| 리서리스테라퓨틱스주식회사 Research Therapeutics Co., Ltd. corporate research center | 5–9 | #403 | ||
| 주식회사 미라큐어 Miracure Co., Ltd. | 5–9 | #406 | ||
| 주식회사 엔비언스 Enviance Co., Ltd. | 5–9 | #402 | ||
| 주식회사 엔도큐라 Endocura Co., Ltd. | 5–9 | #401 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is AUTOPHAGY SCIENCES INC located?
AUTOPHAGY SCIENCES INC is registered at 서울특별시 구로구 디지털로31길, South Korea (postal code 08376).
What industry is AUTOPHAGY SCIENCES INC in?
AUTOPHAGY SCIENCES INC belongs to Professional, Scientific & Technical Services › Research & Development Services › Medical and pharmaceutical research and development industry.
How many employees does AUTOPHAGY SCIENCES INC have?
AUTOPHAGY SCIENCES INC has 5–9 employees.
What is AUTOPHAGY SCIENCES INC's KOBDi Score?
43.37 as of September 2026, ahead of about 68% of companies in its industry.
Who are AUTOPHAGY SCIENCES INC's competitors?
Similar companies include Inoselgen, Research Therapeutics Co., Ltd. corporate research center and Miracure.

